IL6 and interstitial lung disease: on patients with interstitial lung disease, using a program with an amplitude of 4–6 mm and a frequency of 6–26 Hz, revealed a reduction of −1 pg/mL in serum IL-6 levels in the intervention group, while the control group remained unchanged (49).